TPIDB > Principal Investigator
Principal Investigator
National Taiwan University Hospital
(在職)
Division of General Internal Medicine
Division of Cardiovascular Diseases
National Taiwan University Hospital Yunlin Branch
(在職)
Division of General Internal Medicine
Division of Cardiovascular Diseases
更新時間：2025-12-17
高憲立Kao, Hsien Li
- Principal Investigator
- Clinical Trial Experience (year) 23 years 10 個月
-
juching2024@gmail.com
Publication
59Publications
31
Ko TY, Kao HL, Yeh CF, Lin JH, Huang CC, Chen YH, Chao CC, Li HY, Chan CY, Lin LC, Chen YS, Wang MJ, Lin MS. Serial neurocognitive changes following transcatheter aortic valve replacement: comparison between low and intermediate-high risk groups. Aging (Albany NY). 2022 Aug 5;14(15):6111-6127. doi: 10.18632/aging.204202. Epub 2022 Aug 5. PMID: 35939340; PMCID: PMC9417238.
32
Ko TY, Lin JH, Huang KC, Wei LY, Ho YL, Kao HL, Yu HY. Effects of short-term oral anticoagulation following surgical bioprosthesis aortic valve replacement. J Formos Med Assoc. 2023 Jan;122(1):58-64. doi: 10.1016/j.jfma.2022.08.006. Epub 2022 Aug 31.PMID: 36057527
33
Ko TY, Lin TT, Hsu JC, Yang YY, Chuang SL, Lin LY, Kao HL, Ho YL. Incidence, risk factors and predictors of cardiovascular mortality for aortic stenosis among patients with diabetes mellitus. Diabetes Res Clin Pract. 2022 Sep;191:110050. doi: 10.1016/j.diabres.2022.110050. Epub 2022 Aug 27.PMID: 36030901
34
Lee CH, Wang CY, Kao HL, Wu WK, Kuo CH. Differentiation of Alkyl- and Plasmenyl-phosphatidylcholine by Endogenous Sphingomyelin RT-XLOGP3 Regression for Coronary Artery Disease Plasma Lipidomics Analysis. Anal Chem. 2023 Nov 21;95(46):16902-16910. doi: 10.1021/acs.analchem.3c02693. Epub 2023 Nov 6.PMID: 37931321
35
Lee CK, Wang TD, Lee YH, Fahy M, Lee CH, Sung SH, Kao HL, Wu YW, Lin TH. Efficacy and Safety of Renal Denervation for Patients with Uncontrolled Hypertension in Taiwan: 3-Year Results From the Global SYMPLICITY Registry-Taiwan (GSR-Taiwan). Acta Cardiol Sin. 2019 Nov;35(6):618-626. doi: 10.6515/ACS.201911_35(6).20190826A. PMID: 31879514; PMCID: PMC6859098.
36
Lee JH, Ahn JM, Kang DY, Kim KW, Koo HJ, Yang DH, Jung SC, Kim B, Wong YTA, Lam CCS, Yin WH, Wei J, Lee YT, Kao HL, Lin MS, Ko TY, Kim WJ, Kang SH, Yun SC, Ko E, Park H, Lee SA, Kim DH, Park SJ, Park DW; ADAPT-TAVR Investigators. Effect of Edoxaban Versus Antiplatelet Therapy on Leaflet Thrombosis and Cerebral Thromboembolism After TAVI According to Major Clinical and Anatomic Factors in Prespecified Subgroup Analysis from the ADAPT-TAVR Trial. Am J Cardiol. 2023 Sep 15;203:352-361. doi: 10.1016/j.amjcard.2023.06.018. Epub 2023 Jul 28.PMID: 37517131
37
Liao HY, Wang CY, Lee CH, Kao HL, Wu WK, Kuo CH. Development of an Efficient and Sensitive Chemical Derivatization-Based LC-MS/MS Method for Quantifying Gut Microbiota-Derived Metabolites in Human Plasma and Its Application in Studying Cardiovascular Disease. J Proteome Res. 2021 Jul 2;20(7):3508-3518. doi: 10.1021/acs.jproteome.1c00147. Epub 2021 May 31. PMID: 34053222.
38
Lim Y, Gochuico CFS, D'Ascenzo F, Ho KW, Lin MS, Gil IJN, Ielasi A, Tespili M, Mejía AC, DePaoli A, Yap J, Kao HL, Lee MK, Tay E. Assessing the Impact of Transcatheter Aortic Valve Implantation on Cardiac Catheterisation: A Multicentric Study. Heart Lung Circ. 2021 Sep;30(9):1397-1405. doi: 10.1016/j.hlc.2021.02.014. Epub 2021 Mar 31. PMID: 33812787.
39
Lin CH, Lin CH, Chung MC, Hung CS, Tseng FY, Er LK, Jia-Yin Hou C, Lin YH, Wu VC, Cheng HM, Kao HL, Wu KD, Lai TS. Aldosterone-to-renin ratio (ARR) as a screening tool for primary aldosteronism (PA). J Formos Med Assoc. 2023 May 10:S0929-6646(23)00145-6. doi: 10.1016/j.jfma.2023.04.019. Online ahead of print.PMID: 37173226
40
Liu LW, Kao HL, Chen YH, Chiang JY, Yeh CF, Huang CC, Chao CC, Chen YF, Liu YB, Lin MS. On-table catheter-based neurosalvage performed by cardiologists for embolic complication during an endovascular procedure. Acta Cardiol Sin. 2023 Jan;39(1):162-168. doi: 10.6515/ACS.202301_39(1).20220425C.PMID: 36685163
